2 weeks Ago By ABMN Staff
Bruker Co. ( NASDAQ:BRKR – Free Report ) – Investment analysts at Zacks Research boosted their Q3 2025 EPS estimates for shares of Bruker in a research report issued to clients and investors on Tuesday, August 27th. Zacks Research analyst R.
Department now anticipates that the medical research company will post earnings of $0.96 per share for the quarter, up from their prior forecast of $0.95.
The consensus estimate for Bruker’s current full-year earnings is $2.66 per share. Several other research analysts also recently issued reports on the company.
TD Cowen cut their price target on Bruker from $74.00 to $72.00 and set a “hold” rating for the company in a research note on Wednesday, August 7th.
StockNews.com cut Bruker from a “buy” rating to a “hold” rating in a research note on Tuesday, May 21st. Stifel Nicolaus lowered their price target on Bruker from $81.
00 to $77.00 and set a “hold” rating on the stock in a report on Monday, May 20th. Bank of America lowered their target price on Bruker from $95.
00 to $90.00 and set a “buy” rating on the stock in a report on Monday, May 20th. Finally, Wells Fargo & Company started coverage on Bruker in a research report on Tuesday.
They set an “overweight” rating and a $78.00 price objective for the company. One analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company’s stock.
Based on data from MarketBeat, Bruker has a consensus rating of “Moderate Buy” and an average price target of $81.40. Bruker Stock Down 0.
5 % BRKR stock opened at $67.19 on Friday. The company has a current ratio of 1.
81, a quick ratio of 0.91 and a debt-to-equity ratio of 0.95.
The stock has a market cap of $9.77 billion, a P/E ratio of 24.43, a PEG ratio of 2.
39 and a beta of 1.20. The company’s 50 day moving average is $63.
87 and its two-hundred day moving average is $74.76. Bruker has a twelve month low of $53.
79 and a twelve month high of $94.86. Bruker ( NASDAQ:BRKR – Get Free Report ) last posted its quarterly earnings data on Tuesday, August 6th.
The medical research company reported $0.52 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.52.
Bruker had a net margin of 13.38% and a return on equity of 27.31%.
The company had revenue of $800.70 million during the quarter, compared to analysts’ expectations of $799.44 million.
During the same period in the prior year, the business posted $0.50 earnings per share. The firm’s revenue for the quarter was up 17.
4% on a year-over-year basis. Bruker Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 16th. Stockholders of record on Monday, September 2nd will be paid a $0.
05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.
30%. The ex-dividend date of this dividend is Friday, August 30th. Bruker’s dividend payout ratio is 7.
27%. Institutional Trading of Bruker A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BRKR. Norges Bank purchased a new position in shares of Bruker in the 4th quarter worth approximately $74,582,000.
Marshall Wace LLP lifted its stake in Bruker by 127.8% in the second quarter. Marshall Wace LLP now owns 1,389,537 shares of the medical research company’s stock valued at $88,666,000 after purchasing an additional 779,549 shares during the last quarter.
Point72 Asset Management L.P. purchased a new position in Bruker in the second quarter valued at approximately $36,472,000.
TD Asset Management Inc lifted its stake in Bruker by 51.1% in the fourth quarter. TD Asset Management Inc now owns 1,664,779 shares of the medical research company’s stock valued at $122,328,000 after purchasing an additional 562,684 shares during the last quarter.
Finally, Public Employees Retirement Association of Colorado lifted its stake in Bruker by 925.8% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 362,035 shares of the medical research company’s stock valued at $26,602,000 after purchasing an additional 326,741 shares during the last quarter.
79.52% of the stock is owned by institutional investors. About Bruker ( Get Free Report ) Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. Featured Stories Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter .
.
